Buy Lupin, target Rs 834: Kunal Bothra
Buy Lupin Ltd. at a price target of Rs 834 and a stop loss at Rs 795 from entry point.

Lupin Ltd., incorporated in 1983, is a largecap company with a market cap of Rs 36656.52 crore. Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 12236.95 Crore to Sales Value (95.95 % of Total Sales), Export Incentives which contributed Rs 348.04 Crore to Sales Value (2.72 % of Total Sales), Other Services which contributed Rs 161.13 Crore to Sales Value (1.26 % of Total Sales) and Other Operating Revenue which contributed Rs 7.03 Crore to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 31-03-2018, the company has reported a Consolidated sales of Rs 3978.49 Crore, up 2.00 % from last quarter Sales of Rs 3900.36 Crore and down -4.41 % from last year same quarter Sales of Rs 4161.88 Crore Company has reported net profit after tax of Rs -778.86 Crore in latest quarter. The company’s top management includes Dr.Desh Bandhu Gupta, Dr.K U Mada, Dr.Kamal K Sharma, Dr.Vijay Kelkar, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Gupta, Mr.R A Shah, Mr.Ramesh Swaminathan, Mr.Richard Zahn, Mrs.Manju D Gupta, Ms.Vinita Gupta. Company has B S R & Co. LLP as its auditoRs As on 31-03-2018, the company has a total of 452,082,850 shares outstanding.
Download ET Markets APP